Gastroenterology -Therapeutics & Hepatology

New Approaches to Peptic Ulcer Disease

Peptic ulcer disease (PUD), characterized by sores on the stomach or intestinal lining, has seen significant advancements in treatment approaches, improving patient outcomes. Traditional therapies included proton pump inhibitors (PPIs) and antibiotics for Helicobacter pylori eradication, but new approaches are enhancing management strategies. Novel PPI formulations and potassium-competitive acid blockers offer improved acid suppression and faster symptom relief. Additionally, advances in endoscopic techniques, such as argon plasma coagulation and endoscopic submucosal dissection, are providing more effective treatment options for complicated ulcers and related bleeding. Research into alternative therapies, including probiotics and mucosal protectants, is exploring ways to support gut health and enhance healing. Furthermore, personalized medicine approaches, utilizing genetic and molecular profiling, are enabling tailored treatments that address individual patient needs. These new strategies are advancing the management of PUD, aiming for better healing rates, reduced recurrence, and improved overall quality of life for patients.